MYH11基因新变异与家族性胸主动脉瘤病例
该文报告一个家族中三名男性成员携带MYH11基因杂合错义变异,均表现为胸主动脉瘤或扩张。该变异预测为有害且影响肌球蛋白尾部保守氨基酸,被认为是该家族性胸主动脉瘤的致病原因。
要点
- MYH11基因变异与家族性胸主动脉瘤相关。
- 三名男性家族成员携带同一错义变异且均有胸主动脉瘤/扩张。
- 该变异预测有害并影响保守氨基酸。
核心结论
- 该MYH11基因罕见错义变异可能是该家族性胸主动脉瘤的致病原因。
研究设计与样本
- 家族性病例的遗传学分析,涉及同一家族三名男性成员。
主要发现
- 三名男性家族成员均携带MYH11基因杂合错义变异,且均表现为胸主动脉瘤/扩张。
- 该变异预测为有害,并影响肌球蛋白尾部一个保守氨基酸。
- 临床表达符合遗传性动脉瘤的全部特征。
临床怎么用
- 对家族性胸主动脉瘤患者可考虑MYH11基因检测以明确遗传病因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
MYH11 (myosin heavy chain 11) gene is involved in vascular contractility and several autosomal dominant mutations have been linked to thoracic aortic aneurysms. Three male members of the same family were found to carry a heterozygous missense variant in the MYH11 gene and all 3 individuals presented a thoracic aortic aneurysm/dilation. We identified a rare missense variant in the MYH11 gene predicted to be damaging and affecting a conserved amino acid in the myosin tail of the protein. This variant appears to be responsible for our familial case of thoracic aortic aneurysms, as the clinical expression reunited all features of genetic aneurysms.
引用
- Pucci L, Pointet A, Good JM, et al. A New Variant in the MYH11 Gene in a Familial Case of Thoracic Aortic Aneurysm. Ann Thorac Surg. 2019. PMID: 31473177. doi:10.1016/j.athoracsur.2019.07.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。